|
Volumn 65, Issue 6, 2000, Pages 379-389
|
Treatment outcome in patients younger than 60 years with advanced stages (IIB-IV) of Hodgkin's disease: The Swedish National Heath Care Programme experience
|
Author keywords
Advanced stages; Hodgkin's disease; Prognostic factors; Treatment
|
Indexed keywords
BLEOMYCIN;
CHLORAMBUCIL;
CHLORMETHINE;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DOXORUBICIN;
ETOPOSIDE;
LACTATE DEHYDROGENASE;
PREDNIMUSTINE;
PREDNISONE;
PROCARBAZINE;
SERUM ALBUMIN;
VINBLASTINE;
VINCRISTINE;
VINCRISTINE SULFATE;
ACUTE LEUKEMIA;
ADOLESCENT;
ADULT;
ADVANCED CANCER;
AGE;
AMENORRHEA;
ARTICLE;
BONE MARROW METASTASIS;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CARDIOTOXICITY;
FEMALE;
HODGKIN DISEASE;
HUMAN;
HYPOTHYROIDISM;
LACTATE DEHYDROGENASE BLOOD LEVEL;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PUBLIC HEALTH;
SOLID TUMOR;
SWEDEN;
TREATMENT OUTCOME;
ACTUARIAL ANALYSIS;
ADOLESCENT;
ADULT;
ANTINEOPLASTIC AGENTS;
COHORT STUDIES;
DISEASE-FREE SURVIVAL;
FEMALE;
FOLLOW-UP STUDIES;
HODGKIN DISEASE;
HUMANS;
MALE;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
NATIONAL HEALTH PROGRAMS;
NEOPLASM STAGING;
RADIOTHERAPY, ADJUVANT;
RECURRENCE;
RETROSPECTIVE STUDIES;
RISK FACTORS;
SURVIVAL RATE;
SWEDEN;
TREATMENT OUTCOME;
|
EID: 0033665426
PISSN: 09024441
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1600-0609.2000.065006379.x Document Type: Article |
Times cited : (18)
|
References (27)
|